Literature DB >> 10517778

Fatigability of rat hindlimb muscles after acute irreversible acetylcholinesterase inhibition.

R Panenic1, V Gisiger, P F Gardiner.   

Abstract

The purpose of this study was to investigate the functional impact of acute irreversible inhibition of acetylcholinesterase (AChE) on the fatigability of medial gastrocnemius and plantaris muscles of Sprague-Dawley rats. After treatment with methanesulfonyl fluoride (a lipid-soluble anticholinesterase), which reduced their AChE activity by >90%, these muscles were subjected to an in situ indirect stimulation protocol, including a series of isolated twitch and tetanic contractions preceding a 3-min fatigue regimen (100-ms trains at 75 Hz applied every 1.5 s). During the first minute of the fatigue regimen, the effects of AChE inhibition were already near maximal, including marked reductions in peak tension and the force-time integral (area), as well as a decrement of compound muscle action potential amplitudes within a stimulus train. Neuromuscular transmission failure was the major contributor of the force decreases in the AChE-inhibited muscles. However, despite this neuromuscular transmission failure, muscles of which all AChE molecular forms were nearly completely inhibited were still able to function, although abnormally, during 3 min of intermittent high-frequency nerve stimulation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10517778     DOI: 10.1152/jappl.1999.87.4.1455

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  2 in total

1.  Aging influences adaptations of the neuromuscular junction to endurance training.

Authors:  M R Deschenes; M A Roby; E K Glass
Journal:  Neuroscience       Date:  2011-06-13       Impact factor: 3.590

2.  Chronic acetylcholinesterase overexpression induces multilevelled aberrations in mouse neuromuscular physiology.

Authors:  Noa Farchi; Hermona Soreq; Binyamin Hochner
Journal:  J Physiol       Date:  2003-01-01       Impact factor: 5.182

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.